Abstract
A prospective, randomised controlled trial of surgery, surgery with adjuvant radiotherapy and surgery with adjuvant chemotherapy (5-fluorouracil, adriamycin and mitomycin C) in operable gastric cancer is described. Four hundred and thirty-six patients were randomly allocated to one of three treatment groups. With 12 months' minimum follow-up, 334 patients have died, 292 from recurrent cancer. The median survival for all patients was 15 months. Neither form of adjuvant therapy provides any survival advantage. Surgery remains the principal treatment for operable gastric cancer. Care should be taken to standardise surgical treatment and any adjuvant treatments must be compared within the confines of controlled, randomised trials.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allum W. H., Hallissey M. T., Kelly K. A. Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial. Lancet. 1989 Mar 18;1(8638):571–574. doi: 10.1016/s0140-6736(89)91607-3. [DOI] [PubMed] [Google Scholar]
- Cunningham D., Soukop M., McArdle C. S., Carter D. C., Smyth J. F., Allan S. G., Kaye S. B., Sangster G., Calman K. C., Hutcheon A. W. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C. Br J Surg. 1984 Sep;71(9):673–676. doi: 10.1002/bjs.1800710909. [DOI] [PubMed] [Google Scholar]
- Fielding J. W., Fagg S. L., Jones B. G., Ellis D., Hockey M. S., Minawa A., Brookes V. S., Craven J. L., Mason M. C., Timothy A. An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British Stomach Cancer Group. World J Surg. 1983 May;7(3):390–399. doi: 10.1007/BF01658089. [DOI] [PubMed] [Google Scholar]
- Gunderson L. L., Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):1–11. doi: 10.1016/0360-3016(82)90377-7. [DOI] [PubMed] [Google Scholar]
- Imanaga H., Nakazato H. Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg. 1977 Mar;2(1):213–221. doi: 10.1007/BF01665086. [DOI] [PubMed] [Google Scholar]
- MacDonald J. S., Schein P. S., Woolley P. V., Smythe T., Ueno W., Hoth D., Smith F., Boiron M., Gisselbrecht C., Brunet R. 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med. 1980 Oct;93(4):533–536. doi: 10.7326/0003-4819-93-4-533. [DOI] [PubMed] [Google Scholar]
- McNEER G., VANDENBERG H., Jr, DONN F. Y., BOWDEN L. A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann Surg. 1951 Jul;134(1):2–7. doi: 10.1097/00000658-195107000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakajima T., Fukami A., Ohashi I., Kajitani T. Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int J Clin Pharmacol Biopharm. 1978 May;16(5):209–216. [PubMed] [Google Scholar]
- Nissen-Meyer R., Kjellgren K., Malmio K., Månsson B., Norin T. Surgical adjuvant chemotherapy: results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer. 1978 Jun;41(6):2088–2098. doi: 10.1002/1097-0142(197806)41:6<2088::aid-cncr2820410604>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
- Robinson E., Cohen Y. The combination of surgery, radiotherpy, and chemotherapy in the treatment of gastric cancer. Recent Results Cancer Res. 1977;(62):177–180. doi: 10.1007/978-3-642-81174-6_26. [DOI] [PubMed] [Google Scholar]
- Wieland C., Hymmen U. Megavolttherapie maligner Neoplasien des Magens. Strahlentherapie. 1970 Jul;140(1):20–26. [PubMed] [Google Scholar]